Brenda Fewings
Linda Tierney
Jodie Evans
Congratulations to all.
A week to go until the Milton Park Christmas market
 |
 |
 |
||||||
 |
.jpg?t=1512390173034&width=600&name=Milton%20Park%20Christmas%20Fair%202015%20(55).jpg "Milton Park Christmas Fair 2015 (55).jpg") |
| The annual Christmas Market is a week today. Join us and grab some last minute Christmas gifts and really get into the Christmas spirit! | ||
| This year we will be joined by a variety of stall holders including: Ann Laing flowers, Well Preserved, Moreish Must Haves, Phoenix Trading, Blackberry Cottage and many more.
Come along to enjoy some complimentary mulled wine, pigs in blankets and minced pies whilst listening to some Christmas Carols and browsing the stalls. There will be a Christmas jumper competition for those of you with the jazziest and most outrageous jumpers. Christmas champagne will be up for grabs as a prize. The details: When: Friday 15th December Where: Park Centre (white canopy) Time: 11am – 2pm |
||
| For more information, please contact Nancy Leadley on nleadley@mepc.com.
P.S. Have you played our Christmas Game? www.miltonpark.co.uk/ Win some great prizes every day until 22nd December! |
||
November 100 club winners:
Dave Webb, Mette Bradfield, Jane Rapley, top prize was £36.25.
Cannabinoid, Dronabinol, Seen as Long-term Treatment Option for Neuropathic Pain in Phase 3 Study
Source Multiple Sclerosis News Today:
Multiple sclerosis (MS) patients being treated with dronabinol, a cannabinoid, do not show signs of drug abuse or dependency, leading researchers to conclude it has potential to be a long-term and safe treatment option for neuropathic pain.
The issue of pain management, specifically central neuropathic pain (CNP), in patients with autoimmune disorders such as MS is largely unresolved. Dronabinol, whose active compound comes from medical cannabis, is often used to ease nausea and vomiting caused by chemotherapy. It may also treat chronic pain and has been investigated in a few clinical trials.
But its use remains controversial because of concerns with, and lack of data about, its psychotropic side effects and potential for dependency. Read on.
Ozanimod Superior to Avonex in Treating Relapsing MS in Phase 3 Trials, Celgene Reports
Source Multiple Sclerosis News Today: 
Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated with ozanimod had lower relapse rates and fewer MRI brain lesions compared to those given a current first-line therapy, Avonex (interferon β-1a).
These results will be used to support a request for ozanimod’s approval as an MS therapy with the U.S. Food and Drug Administration (FDA), a filing known as a New Drug Application. Read on.
The MS Society explore 5 myths about cannabis and MS
Source MS Society:
There’s mounting evidence to show that cannabis could help pain and muscle spasms for people with MS. But with tonnes of information swirling around the internet, it’s hard to be sure what’s true and what’s not.
We dived into the details to bust 5 common myths about cannabis and MS:
1. ‘Cannabis for medicinal use’ means any kind of cannabis
This can be confusing, as the media often refers to both licensed cannabis products and the illegal drug as ‘medicinal cannabis’.
What medical professionals usually mean by ‘medicinal cannabis’ or ‘medical cannabis’ is cannabis products licensed as medical treatments. So for MS, that means Sativex, which is specifically licensed to treat muscle spasms and stiffness in MS. Journalists or other people using the phrase could mean cannabis used for any medical purpose.
We’re calling for the Government to legalise cannabis for two medicinal purposes: to treat pain and spasticity when other treatments haven’t worked. Read on.
MS Aqua Classes Starting Again
MS Aqua Classes are available at Richmond Village in Witney.
The classes will be on Mondays from 11.30-12.30 and will be £10 per session. The dates for this year will be Monday 27th Nov, and then 4th, 11th, 18th December. If all goes well, I will then run sessions in 6 week blocks roughly in line with term times.
Please let Caroline know if you wish to attend.
The classes are called MS AquaPower, and are physio-led, run by ONPhysio. Contact is as below:
Caroline Hyne
Clinical Specialist Physiotherapist
Oxfordshire Neurophysiotherapy
07702884531
Aiden William Tolmie
Congratulations Jodie on the safe arrival of Aiden William Tolmie.
London Marathon Charity Place
We are delighted Miles Jones, MEPC Development Manager is running for us in the London Marathon he is hoping to raise £1,500.
Please click on link to donate:-
http://uk.virginmoneygiving.com/fundraiser-web/fundraiser/showFundraiserProfilePage.action?userUrl=MiltonPark
Booking of appointments from 1st January
From 1st January the Committee has decided the booking of all appointments shall be as follows:
MS members can book up to 6 weeks in advance
Non-ms members/carers can book up to 3 weeks in advance
This will go some way to reinforcing that MS members take priority.
